BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30983034)

  • 1. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
    Dodds M; Maguiness S
    Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
    Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
    Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
    Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
    Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial acanthosis nigricans due to K650T FGFR3 mutation.
    Berk DR; Spector EB; Bayliss SJ
    Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
    Mir A; Wu T; Orlow SJ
    JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population.
    Coerdt KM; Todd SP; DeKlotz CMC
    Pediatr Dermatol; 2021 Jan; 38(1):296-298. PubMed ID: 33099783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
    Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
    Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
    Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
    J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
    Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
    J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
    Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
    J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic FGFR3 and FGFR2 mutations.
    Bessis D; Petit A; Battistella M; Bourrat E; Girard C; Pallure V; Marque M; Lacour JP; Vitetta A; Bieth É; Selves J; Solassol J; Vendrell J
    Br J Dermatol; 2019 Apr; 180(4):955-957. PubMed ID: 30580445
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensive segmental acanthosis nigricans form of epidermal nevus.
    de Waal AC; van Rossum MM; Bovenschen HJ
    Dermatol Online J; 2010 Jun; 16(6):7. PubMed ID: 20579462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.
    Berk DR; Boente Mdel C; Montanari D; Toloza MG; Primc NB; Prado MI; Bayliss SJ; Pique LM; Schrijver I
    Pediatr Dermatol; 2010; 27(6):664-6. PubMed ID: 21510009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A hypothesis on the pathogeny of rounded and linear epidermal nevi (nevoid acanthosis nigricans)].
    Vabres P
    Ann Dermatol Venereol; 2012 Mar; 139(3):177-9. PubMed ID: 22401680
    [No Abstract]   [Full Text] [Related]  

  • 15. The acanthosis nigricans form of epidermal nevus.
    Ersoy-Evans S; Sahin S; Mancini AJ; Paller AS; Guitart J
    J Am Acad Dermatol; 2006 Oct; 55(4):696-8. PubMed ID: 17010754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
    Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
    Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.
    Leroy JG; Nuytinck L; Lambert J; Naeyaert JM; Mortier GR
    Am J Med Genet A; 2007 Dec; 143A(24):3144-9. PubMed ID: 18000903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acanthosis nigricans in children and Crouzon syndrome].
    Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
    Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crouzon syndrome with acanthosis nigricans: a case-based update.
    Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
    Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
    Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
    J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.